Autor: "Sivalingam VN" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer.
Autorzy:: Njoku K; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, 5th Floor Research, St Mary's Hospital, Oxford Road, Manchester M13 9WL, UK.; Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.; Stoller Biomarker Discovery Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
Campbell AE; Stoller Biomarker Discovery Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
Geary B; Stoller Biomarker Discovery Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
MacKintosh ML; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, 5th Floor Research, St Mary's Hospital, Oxford Road, Manchester M13 9WL, UK.; Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Derbyshire AE; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, 5th Floor Research, St Mary's Hospital, Oxford Road, Manchester M13 9WL, UK.; Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Kitson SJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, 5th Floor Research, St Mary's Hospital, Oxford Road, Manchester M13 9WL, UK.; Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Sivalingam VN; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, 5th Floor Research, St Mary's Hospital, Oxford Road, Manchester M13 9WL, UK.; Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Pierce A; Wolfson Molecular Imaging Centre, Division of Cancer Sciences, University of Manchester, Palatine Road, Manchester M20 3LJ, UK.
Whetton AD; Stoller Biomarker Discovery Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.; Wolfson Molecular Imaging Centre, Division of Cancer Sciences, University of Manchester, Palatine Road, Manchester M20 3LJ, UK.
Crosbie EJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, 5th Floor Research, St Mary's Hospital, Oxford Road, Manchester M13 9WL, UK.; Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 Feb 10; Vol. 13 (4). Date of Electronic Publication: 2021 Feb 10.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Autorzy:: Ryan NAJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.; Division of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
McMahon R; Department of Pathology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Tobi S; Manchester Centre for Genomic Medicine, North-West Genomics Laboratory Hub, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Snowsill T; Health Economics Group, University of Exeter Medical School, University of Exeter, Exeter, Devon, United Kingdom.
Esquibel S; Department of Pathology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Wallace AJ; Manchester Centre for Genomic Medicine, North-West Genomics Laboratory Hub, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Bunstone S; Manchester Centre for Genomic Medicine, North-West Genomics Laboratory Hub, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Bowers N; Manchester Centre for Genomic Medicine, North-West Genomics Laboratory Hub, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Mosneag IE; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Kitson SJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
O'Flynn H; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Ramchander NC; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Sivalingam VN; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Frayling IM; Inherited Tumour Syndromes Research Group, Institute of Cancer & Genetics, Cardiff University, Cardiff, United Kingdom.
Bolton J; Department of Pathology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
McVey RJ; Department of Pathology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Evans DG; Division of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.; Manchester Centre for Genomic Medicine, North-West Genomics Laboratory Hub, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Crosbie EJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.; Department of Obstetrics and Gynaecology, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2020 Sep 17; Vol. 17 (9), pp. e1003263. Date of Electronic Publication: 2020 Sep 17 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Early Detection of Cancer/*methods
Endometrial Neoplasms/*genetics
Adult ; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics ; Colorectal Neoplasms, Hereditary Nonpolyposis/pathology ; Cross-Sectional Studies ; DNA Methylation/genetics ; DNA Mismatch Repair/genetics ; Endometrial Neoplasms/diagnosis ; Female ; Genetic Testing/methods ; Humans ; Immunohistochemistry ; Mass Screening/methods ; Microsatellite Instability ; Middle Aged ; Prospective Studies ; Sensitivity and Specificity ; United Kingdom

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Detecting Endometrial Cancer by Blood Spectroscopy: A Diagnostic Cross-Sectional Study.
Autorzy:: Paraskevaidi M; School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, UK.; Department of Metabolism, Institute of Reproductive and Developmental Biology, Digestion and Reproduction & Surgery and Cancer, Imperial College London, London W12 0HS, UK.
Morais CLM; School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, UK.
Ashton KM; Pathology Department, Lancashire Teaching Hospitals NHS Foundation, Preston PR2 9HT, UK.
Stringfellow HF; Pathology Department, Lancashire Teaching Hospitals NHS Foundation, Preston PR2 9HT, UK.
McVey RJ; Pathology Department, Manchester University Hospitals NHS Foundation Trust, Manchester M13 9WL, UK.
Ryan NAJ; Division of Cancer Sciences, University of Manchester, Manchester M13 9WL, UK.
O'Flynn H; Division of Cancer Sciences, University of Manchester, Manchester M13 9WL, UK.
Sivalingam VN; Division of Cancer Sciences, University of Manchester, Manchester M13 9WL, UK.
Kitson SJ; Division of Cancer Sciences, University of Manchester, Manchester M13 9WL, UK.
MacKintosh ML; Department of Obstetrics and Gynaecology, Manchester University Hospitals NHS Foundation Trust, Manchester M13 9WL, UK.
Derbyshire AE; Department of Obstetrics and Gynaecology, Manchester University Hospitals NHS Foundation Trust, Manchester M13 9WL, UK.
Pow C; Division of Cancer Sciences, University of Manchester, Manchester M13 9WL, UK.
Raglan O; Department of Metabolism, Institute of Reproductive and Developmental Biology, Digestion and Reproduction & Surgery and Cancer, Imperial College London, London W12 0HS, UK.
Lima KMG; Department of Chemistry, Biological Chemistry and Chemometrics, Federal University of Rio Grande do Norte, Natal 59072-970, Brazil.
Kyrgiou M; Department of Metabolism, Institute of Reproductive and Developmental Biology, Digestion and Reproduction & Surgery and Cancer, Imperial College London, London W12 0HS, UK.; West London Gynaecological Cancer Centre, Queen Charlotte's & Chelsea-Hammersmith Hospital, Imperial Healthcare NHS Trust, London W12 0HS, UK.
Martin-Hirsch PL; Department of Obstetrics and Gynaecology, Lancashire Teaching Hospitals NHS Foundation, Preston PR2 9HT, UK.
Martin FL; School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, UK.
Crosbie EJ; Division of Cancer Sciences, University of Manchester, Manchester M13 9WL, UK.; Department of Obstetrics and Gynaecology, Manchester University Hospitals NHS Foundation Trust, Manchester M13 9WL, UK.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2020 May 16; Vol. 12 (5). Date of Electronic Publication: 2020 May 16.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer.
Autorzy:: Latif A; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Chadwick AL; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Level 5 - Research, St Mary's Hospital, Oxford Road, Manchester, M13 9WL UK.
Kitson SJ; Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Level 5 - Research, St Mary's Hospital, Oxford Road, Manchester, M13 9WL UK.
Gregson HJ; Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Level 5 - Research, St Mary's Hospital, Oxford Road, Manchester, M13 9WL UK.
Sivalingam VN; Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Level 5 - Research, St Mary's Hospital, Oxford Road, Manchester, M13 9WL UK.
Bolton J; Department of Histopathology, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
McVey RJ; Department of Histopathology, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Roberts SA; Division of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Marshall KM; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Williams KJ; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Stratford IJ; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Crosbie EJ; Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Level 5 - Research, St Mary's Hospital, Oxford Road, Manchester, M13 9WL UK.; Department of Obstetrics and Gynaecology, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; Pokaż więcej
Źródło:: BMC clinical pathology [BMC Clin Pathol] 2017 Dec 28; Vol. 17, pp. 27. Date of Electronic Publication: 2017 Dec 28 (Print Publication: 2017).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Sivalingam VN"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język